20250613_SILO_Laporan Informasi dan Fakta Material_31895041_lamp2.pdf

kidney transplants with high survival rates and strong post-transplant quality of life outcomes. These
achievements demonstrate that Siloam has already established itself as a healthcare provider of
international quality.

Sustainable Impact for Indonesia

Siloam continues to embed Environmental, Social, and Governance (ESG) principles into its operations,
ensuring that sustainability is not only a value but also a practice across its hospital network. This includes
initiatives to improve energy and water efficiency, responsible waste management, digital transformation
to reduce paper consumption, and strengthening supplier standards in alignment with environmental
and social expectations. As a result of its ongoing efforts, Siloam is currently ranked in the top 21% of
healthcare organizations globally for sustainability, based on an independent ESG assessment. This
reflects the Company’s commitment to responsible business practices and long-term value creation for
all stakeholders.

Under its Caring for Community pillar, Siloam operates seven free clinics in remote areas of Papua,
ensuring access to essential healthcare in underserved regions. In another expression of this
commitment, Siloam provides free breast cancer screening services at 32 hospitals across the network.
Over the past two years, nearly 40,000 women have been screened through this program—making a
tangible impact on early detection and prevention.

2024: A Year of Strong Growth and Operational Excellence

Siloam delivered stable financial results despite ongoing macroeconomic and industry challenges. The
Company recorded revenue of Rp 12.2 trillion, underlying EBITDA of Rp 2.76 trillion, and net profit of Rp
950 billion—driven by strong inpatient and outpatient growth, operational efficiency, and a continued
focus on patient care. Over the past five years under the Siloam 5.0 strategy, revenue has increased by
72% and EBITDA by 177%. Regarding dividends, it was decided that the entire net profit for 2024 will be
retained as part of the Company’s earnings; therefore, no dividend will be distributed for this financial
year. For Siloam, strong financial performance ultimately reflects the trust the public places in its services.

Operationally, the number of available beds has increased to 7,932. Patient volumes also continued to
grow, with over 4 million outpatient visits, 300,000 inpatient admissions, and more than 100,000 surgical
procedures performed in the year.

Remarks from Siloam’s President Director:

Siloam’s President Director, Mr. David Utama, commented on the results: “ We are proud to report strong
financial results despite challenges, and we remain committed to building Indonesia’s healthcare
ecosystem. Through NGS, we are sharpening our focus on access and quality, expanding our capabilities,
and continuing to invest in our people and technology to serve the nation better.”

For more information, please contact:

Investor Relations
vivian.chandra@siloamhospitals.com


Corporate Communication
corcomm@siloamhospitals.com


About Siloam Hospitals Group

PT Siloam International Hospitals Tbk (“Siloam Hospitals”) is a leading private hospital network committed to
providing high-quality healthcare services in Indonesia. Established in 1996, the Siloam Hospitals Grup currently
manages and operates 41 hospitals, including f 15 hospitals in the Greater Jakarta area (Jabodetabek) and 26
hospitals across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara and Ambon. In addition, the Siloam
Hospitals Group also operates 73 Siloam Clinic units to maximize healthcare access for all Indonesians. Founded on
God’s compassion, the Siloam Hospitals group has a vision to provide international quality healthcare services
accessible to all levels of society in Indonesia. In line with this vision, Siloam has also become a trusted choice in
delivering world-class holistic healthcare, as well as continuous medical education and research.

Supported by a medical team consisting of more than 2,000 general practitioners and specialists, and 10,000 nurses
and professional staff, Siloam Hospitals’ medical team works tirelessly to provide the best care, serving nearly two
million patients annually across Indonesia.

Siloam Hospitals Group is a pioneer in achieving Joint Commission International (JCI) accreditation for hospitals in
Indonesia. JCI is an international accreditation agency based in the United States that focuses on setting the highest
standards for healthcare service quality and patient safety.

In 2025, the Siloam Hospitals Group’s commitment to delivering high-quality healthcare services was once again
recognized through five prestigious awards from the Healthcare Asia Awards. These include: Specialty Hospital of
the Year – Indonesia, awarded to MRCCC Siloam Hospitals for its breakthroughs in oncology services. Tertiary
Hospital of the Year – Indonesia, awarded to Siloam Hospitals ASRI for its achievements in kidney transplantation.
Medical Tourism Hospital of the Year – Indonesia, awarded to BIMC Nusa Dua for its success in combining high-
quality plastic surgery services with a world-class medical tourism experience.

Additionally, the Outpatient Digital Express Lane digital innovation received the Service Delivery Innovation
Initiative of the Year – Indonesia award, and the Stroke-Ready Hospitals initiative was honored with the Clinical
Service Initiative of the Year – Indonesia award.

These five awards reflect the Siloam Hospitals Group’s dedication to providing international -standard, patient-
centered healthcare services.

For more information about Siloam Hospitals, visit www.siloamhospitals.com

Disclaimer: This Press Release is prepared by Siloam Hospitals and is distributed only to convey general information. This Press Release is not
intended for a particular group or purpose and does not constitute a recommendation regarding the shares of Siloam Hospitals. No guarantee is
given regarding the completeness or certainty of the information contained. All opinions and estimates included in this Press Release are our
opinions as of this date and are subject to change without notice. Siloam Hospitals is not responsible for any losses that may occur to any party
due to part or all of the contents of this Press Release, Siloam Hospitals and affiliated companies including their employees and agents are not
responsible for any mistakes, omissions, omissions or inaccuracies that can happen.

Predictive Statements: Some of the statements in this Press Release are or may be predictive in nature. These statements generally contain
words such as "will", "hopes", "anticipates" or the like. By their nature, predictive statements carry risks and uncertainties that may cause realities
that are different from what is explained in this Press Release. Factors that can cause different realities include but are not limited to: the
economic, social and political situation in Indonesia; the health industry situation in Indonesia; market situation; additional regulatory burdens
in Indonesia, including regulations relating to the environment and regulatory compliance costs; fluctuations in foreign exchange rates; interest
rate development, capital costs and capital availability; anticipated demand and supply prices related to our health services and related capital
expenditures and other investments; construction costs; availability of health services; competition from companies and other locations; changes
in customer demand; changes in operational costs, including employee salaries, wages and training, changes in public and government policies;
our ability to stay competitive; financial conditions, business strategies and plans and targets set by our management for future work;
procurement of future income; compliance with environmental and remediation regulations. If, among other things, one or more of the risks or
uncertainties mentioned above occur, the actual results may differ materially than predicted, anti cipated or projected. In particular, but not
limited, capital costs can increase, projects can be postponed and anticipated increases in production, capacity or implementation may not all
occur. Although we believe that our management's expectations expressed in predictive statements are reasonable based on the information

we have at the moment, we cannot provide guarantees that these expectations can become reality. You should not depend on these statements
immediately. However, these statements apply only to the date they were stated, and we are not responsible for making updates or revisions,
even if new information, new events or anything is available.